You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
The partners will work to develop and distribute IROA Technologies' kit for chemically labeling metabolites for mass spectrometry analysis.
Scientists led by the Scripps Research Institute's Benjamin Cravatt have developed probes and a mass spec method to find methyltransferases in human cells.
The company will work with Pfizer's Pain & Sensory Disorders and Regenerative Medicine unit on the project using its Episphere chemoproteomics platform.
The acquisition of the chemical proteomics firm allows Evotec it "to take earlier educated decisions on drug efficacy, safety, and response in patients."
Cellzome researchers from Germany and the UK used a chemoproteomic approach to look at protein complexes associated with several histone deacetylase inhibitors.
Two COVID-19 vaccine developers have released their trial protocols to build public trust, the New York Times reports.
A new analysis finds the rapid COVID-19 test from DnaNudge to be highly accurate, Reuters reports.
In Science this week: global citizens' assembly on genome-editing technologies proposed, epigenetic markers predict metformin response, and more.
According to the Verge, many US states are not including positive results from rapid COVID-19 testing in their case numbers.